MedTrace Logo

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2756

Last updated 2026-01-08

No results posted yet for this study

Summary

This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, designed to assess the real-world outcomes and safety of atezolizumab for indications in the existing label in the real world setting of routine clinical practice.

Conditions

Interventions

DRUG

Atezolizumab

Atezolizumab will be administered at the discretion of the treating physician per local guidelines and independently of participation in this study.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Argentina
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Chile
  • Colombia
  • Croatia
  • Egypt
  • Estonia
  • France
  • Hungary
  • India
  • Italy
  • Kuwait
  • Lebanon
  • Lithuania
  • Mexico
  • Netherlands
  • Oman
  • Pakistan
  • Poland
  • Portugal
  • Romania
  • Russia
  • Singapore
  • Slovenia
  • Spain
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782207 on ClinicalTrials.gov